No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said

No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said

The group did not review information regarding tirzepatide, the medication used in drugs sold as Mounjaro and Zepbound. Read More 

Czytaj więcej

We współpracy z: https://fortune.com/2024/04/12/ozempic-wegovy-risk-of-self-harm-regulators/

Total
0
Shares
Dodaj komentarz

Podobne Wpisy